Delivery Order SPE2DB20D2104-SPE2DB23FQ99L
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,427.95 from the Defense Logistics Agency (DLA) for pharmaceutical and medical products. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,487.20 for the provision of pharmaceutical and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities, including specialty...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $5,311.68 for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The contract has no set-aside designation, indicating open competition. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,745.31 for the provision of pharmaceutical and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,434.96 for pharmaceutical and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,831.50 for pharmaceutical and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 through November 2026. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at up to $1,126.44, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through December 2025. The IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,748.96 for pharmaceutical and medical supply products to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which has no set-aside designation, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA, running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,151.12 awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,078.78 awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FQ99LDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,769.85 for the supply of pharmaceutical products to the Defense Logistics Agency (DLA). The award, which does not have a set-aside designation, is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials, to support military treatment facilities and veterans' healthcare programs globally. In addition, Cencora, Inc. holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 11/7/22 |